Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-23

Clinical Trial Update: Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome [Phase 4]

View source ↗

Summary

This is a Phase 4 randomized trial comparing nebivolol with metoprolol to assess insulin sensitivity and fibrinolytic balance in people with metabolic syndrome.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BYSTOLIC (nebivolol hydrochloride)
  • LOPRESSOR (METOPROLOL TARTRATE)
  • TOPROL XL (METOPROLOL SUCCINATE)

Snippet

Sponsor: Vanderbilt University | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2012-10-23